ClinicalTrials.Veeva

Menu

Testing the Efficacy of the REThink Emotions Platform in a Full-scale SMART Study

B

Babes-Bolyai University

Status

Completed

Conditions

Emotional Regulation

Treatments

Other: REThink Game
Other: MoodWheel
Other: PsyPills

Study type

Interventional

Funder types

Other

Identifiers

NCT06085391
REThink SMARTrial

Details and patient eligibility

About

This activity will have the objective of testing the validity of the integrated in-game assessment and personalized REThinkEMOTIONS platform in the prevention of emotional disorders in youth.

Enrollment

185 patients

Sex

All

Ages

8 to 16 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • children and adolescents between 8 and 16 years old
  • provided written parental consent
  • able to access mobile/internet applications on their device

Exclusion criteria

  • Intellectual disability or physical limitations precluded the use of the computer program
  • Had a major mental health disorder

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Sequential Assignment

Masking

Single Blind

185 participants in 3 patient groups

REThink game
Experimental group
Description:
Each recruited participant randomized in the experimental group will receive the REThink game app.
Treatment:
Other: REThink Game
MoodWheel
Active Comparator group
Description:
The participants randomized in the control group will complete the MoodWheel app.
Treatment:
Other: MoodWheel
PsyPills
Experimental group
Description:
Participants from experimental group who do not respond to REThink game alone will receive the PsyPills app
Treatment:
Other: REThink Game
Other: PsyPills

Trial contacts and locations

1

Loading...

Central trial contact

Oana David; Cristina Tomoiaga

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems